Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
COLL
COLL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
COLL News
Collegium Pharmaceutical EVP Scott Dreyer Sells 17,600 Shares for ~$847,800
Jan 14 2026
Fool
Collegium Pharmaceutical EVP Dreyer Sells 17,600 Shares for ~$847,800
Jan 14 2026
NASDAQ.COM
Collegium Projects 2026 Product Revenues Between $805 Million and $825 Million
Jan 08 2026
Globenewswire
Collegium Pharmaceutical Closes $980 Million Credit Facility, Enhancing Debt Structure
Dec 30 2025
Globenewswire
Collegium Pharmaceutical Closes $980 Million Credit Facility, Enhancing Debt Structure
Dec 30 2025
Newsfilter
Top Value Stocks to Consider Purchasing on December 18
Dec 18 2025
NASDAQ.COM
Ensign Group Strengthens Presence in Three U.S. States Through Facility Acquisitions
Dec 03 2025
NASDAQ.COM
Stock of the Day: Collegium Pharmaceutical (COLL)
Nov 19 2025
NASDAQ.COM
Collegium Pharmaceutical Achieves Analyst Price Target
Nov 13 2025
NASDAQ.COM
Truist Securities Reaffirms Buy Rating for Collegium Pharmaceutical and Increases Price Target to $48
Nov 07 2025
Benzinga
Inaugural Week of COLL June 2026 Options Trading
Nov 07 2025
NASDAQ.COM
Collegium Pharmaceutical Stock Jumps 12% Following Q3 Results and Increased Guidance
Nov 06 2025
NASDAQ.COM
3 High Short Interest Stocks Poised for Explosive Growth
Oct 31 2025
Yahoo Finance
Knight Therapeutics Unveils JORNAY PM™ Launch in Canada
Oct 30 2025
Newsfilter
Knight Therapeutics Unveils JORNAY PM™ Launch in Canada
Oct 30 2025
Globenewswire
Needham Affirms Buy Rating on Collegium Pharmaceutical, Keeps $46 Price Target Intact
Oct 28 2025
Benzinga
Show More News
